Assessment of distress and quality of life of cancer patients over the course of chemotherapy


  • Cristiane Decat Bergerot Psychologist, Ph.D. Centro de Câncer de Brasília (CETTRO), Brasilia, Brasil. email:
  • Tereza Cristina Cavalcanti Ferreira de Araujo Psychologist, Ph.D. Professor Universidade de Brasília. Researcher, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil. email:



Anxiety, quality of life, health services, oncologic nursing, neoplasms


Objective. Assess the prevalence of distress and quality of life of cancer patients over the course of chemotherapy.

Method. Longitudinal prospective study addressing 200 patients. The Distress Thermometer (DT) and Functional Assessment of Chronic Illness Therapy-General (FACT-G), as indicators of distress and quality of life, were applied at three points in time during chemotherapy: the first day (T1), half way through the treatment (T2), and last day of medication (T3).

Results. The average age was 56.8 years old, and 70% were women while the most frequent types of cancer included breast (30%) and hematological (22%) cancers. The number of patients with a high level of distress statistically decreased over time (T1=41.5%, T2=8.0% and T3=2.5%); consequently, quality of life scores improved (T1=85.6%, T2=90.4% and T3=92.0%). Patients with moderate to severe distress experienced worse quality of life. Distress, type of cancer and disease stage significantly impacted quality of life.

Conclusion. There was a reduction in the time of impact from the side effects of chemotherapy in the patients as a consequence of adapting to the diagnosis and treatment. Continuous assessment of the needs of patients is essential to ensuring integral and humanized care, contributing to improved oncological nursing. 

= 703 veces | RESUMEN | RESUMO
= 10 veces| | PDF(ENGLISH)
= 185 veces| | HTML(ENGLISH
= 14 veces| | HTML(PORTUGUES)
= 31 veces|


Download data is not yet available.


(1) Loscalzo M, Clark KL, Holland J. Successful strategies for implementing biopsychosocial screening. Psycho-Oncol. 2011; 20(5):455-62.

(2) Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2011; 84(8)1011-15.

(3) Jacobsen PB, Wagner LI. A new quality standard: the integration of psychosocial care into routine cancer care. J Clin Oncol. 2012; 30:1154-59.

(4) National Comprehensive Cancer Network. Distress management. Clinical practice guidelines. J Natl Compr Canc Netw. 2003; 1(3):344-74.

(5) Block SD. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-life care consensus panel. American College of Physicians - American Society of Internal Medicine. Ann Intern Med. 2000; 132(3):209-18.

(6) Grassi L, Indelli M, Marzola M, Maestri A, Santini A, Piva E, et al. Depressive symptoms and quality of life in home-care-assisted cancer patients. J Pain Symptom Manage. 1996; 12(5):300-7.

(7) Bultz BD, Groff SL, Fitch M, Blais MC, Howes J, Levy K, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psycho-Oncol. 2011; 20(5):463-9.

(8) Ashbury FD, Findlay H, Reynolds B, McKerracher K. A Canadian survey of cancer patients’ experiences: are their needs being met? J Pain Symptom Manage. 1998; 16:298-306.

(9) Gotay CC. Quality-of-life assessment in cancer. In: Miller SM, Bowen DJ, Croyle RT, Rowland JH (Eds.). Handbook of cancer control and behavioral science: a resource for researchers, practitioners, and policymaker. Washington, DC: American Psychological Association; 2009. p.115-28.

(10) Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic intervention on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013; 31(6):782-93.

(11) Costa Neto SB, Araujo TCCF. Qualidade de vida do enfermo oncológico: um panorama sobre o campo e suas formas de avaliação. In Carvalho VA, Franco MHP, Kovács MJ, Liberato RP, Macieira RC, Veit MT, et al (Eds.). Temas em Psico-Oncologia. São Paulo, SP: Summus; 2008. p.195-208.

(12) Bultz BD, Johansen C. Screening for distress, the 6th vital sign: where are we, and where are we going? Psycho-Oncol. 2011; 20(6):569-71.

(13) Andritsch E, Dietmaier G, Hofmann G, Zloklikovits S, Samonigg H. Global quality of life and its potential predictors in breast cancer patients: and exploratory study. Support Care Cancer. 2007; 15:21-30.

(14) Dapueto JJ, Servente L, Francolino C, Hahn EA. Determinants of quality of life in patients with cancer. Cancer. 2005; 103:1072-81.

(15) Anant M, Randeep G, Ashutosh PJ, Manisha B, Hemraj P, Charu M, et al. Quality of life measures in lung cancer. Indian J Cancer. 2005; 42(3):125-32.

(16) Costa-Requena G, Rodríguez A, Fernández-Ortega P. Longitudinal assessment of distress and quality of life in the early stages of breast cancer treatment. Scand J Caring Sci. 2013; 27:77-83.

(17) Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-Oncol. 2001; 10:19-28.

(18) Costa Neto SB, Araujo TCCF. Calidad de vida de los portadores de neoplasia de cabeza y de cuello en fase diagnóstica. Rev Colomb Psicol. 2005; 14:53-63.

(19) Manrique FMC, Pedraza HMP. Prevalence of nursing diagnosis in people with oncology treatment. Invest Educ Enferm. 2008; 26(2):212-7.

(20) Porto AR, Thofehrn MB, Amestoy SC, Gonzáles RIC, Oliveira NA. The essence of interdisciplinary practice in palliative care delivery to cancer patients. Invest Educ Enferm. 2012; 30(2):231-9.

(21) Decat CS, Laros JA, Araujo TCCF. Termômetro de distress: validação de um instrumento breve para avaliação diagnóstica de pacientes oncológicos. Psico-USF. 2009; 14(3):253-60.

(22) Arnold BJ, Eremenco E, Chang CH, Odom L, Ribaudo JM, Cella DF. Development of a single portuguese language version of the functional assessment of cancer therapy general (FACIT-G) scale. Qual Life Res. 2000; 9(3):316.

(23) Carlson LE, Waller A, Mitchell AJ. Screening for distress an unmet needs in patients with cancer: review and recommendations. J Clin Oncol. 2012; 30:1160-77.

(24) Faria SL, Souhami L. Communication with the cancer patient. Information and truth in Brazil. Ann N Y Acad Sci. 1997; 809(1):163-71.

(25) Akechi T, Okuyama T, Akizuki N, Azuma H, Sagawa R, Furukawa TA, et al. Course of psychological distress and its predictors in advanced non-small cell lung cancer patients. Psycho-Oncol. 2006; 15:463-73.



How to Cite

Decat Bergerot, C., & Cavalcanti Ferreira de Araujo, T. C. (2014). Assessment of distress and quality of life of cancer patients over the course of chemotherapy. Investigación Y Educación En Enfermería, 32(2).




Similar Articles

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 > >> 

You may also start an advanced similarity search for this article.